Literature DB >> 22457349

L-MPZ, a novel isoform of myelin P0, is produced by stop codon readthrough.

Yoshihide Yamaguchi1, Akiko Hayashi, Celia W Campagnoni, Akio Kimura, Takashi Inuzuka, Hiroko Baba.   

Abstract

Myelin protein zero (P0 or MPZ) is a major myelin protein (∼30 kDa) expressed in the peripheral nervous system (PNS) in terrestrial vertebrates. Several groups have detected a P0-related 36-kDa (or 35-kDa) protein that is expressed in the PNS as an antigen for the serum IgG of patients with neuropathy. The molecular structure and function of this 36-kDa protein are, however, still unknown. We hypothesized that the 36-kDa protein may be derived from P0 mRNA by stop codon readthrough. We found a highly conserved region after the regular stop codon in predicted sequences from the 3'-UTR of P0 in higher animals. MS of the 36-kDa protein revealed that both P0 peptides and peptides deduced from the P0 3'-UTR sequence were found among the tryptic fragments. In transfected cells and in an in vitro transcription/translation system, the 36-kDa molecule was also produced from the identical mRNA that produced P0. We designated this 36-kDa molecule as large myelin protein zero (L-MPZ), a novel isoform of P0 that contains an additional domain at the C terminus. In the PNS, L-MPZ was localized in compact myelin. In transfected cells, just like P0, L-MPZ was localized at cell-cell adhesion sites in the plasma membrane. These results suggest that L-MPZ produced by the stop codon readthrough mechanism is potentially involved in myelination. Since this is the first finding of stop codon readthrough in a common mammalian protein, detailed analysis of L-MPZ expression will help to understand the mechanism of stop codon readthrough in mammals.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22457349      PMCID: PMC3366853          DOI: 10.1074/jbc.M111.314468

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

Review 1.  Misreading of termination codons in eukaryotes by natural nonsense suppressor tRNAs.

Authors:  H Beier; M Grimm
Journal:  Nucleic Acids Res       Date:  2001-12-01       Impact factor: 16.971

2.  Isolation and sequence determination of cDNA encoding the major structural protein of human peripheral myelin.

Authors:  K Hayasaka; K Nanao; M Tahara; W Sato; G Takada; M Miura; K Uyemura
Journal:  Biochem Biophys Res Commun       Date:  1991-10-31       Impact factor: 3.575

3.  A possible novel isoform of peripheral myelin P0 protein: a target antigen recognized by an autoantibody in a patient with malignant lymphoma and peripheral neuropathy.

Authors:  K Ishida; H Takeuchi; R Takahashi; K Yoshimura; M Yamada; H Mizusawa
Journal:  J Neurol Sci       Date:  2001-07-15       Impact factor: 3.181

4.  Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system.

Authors:  M Manuvakhova; K Keeling; D M Bedwell
Journal:  RNA       Date:  2000-07       Impact factor: 4.942

5.  Serum IgG antibodies to P0 dimer and 35 kDa P0 related protein in neuropathy associated with monoclonal gammopathy.

Authors:  A Favereaux; A Lagueny; A Vital; J-M Schmitter; S Chaignepain; X Ferrer; I Labatut-Cazabat; C Vital; K G Petry
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

6.  Codon context effect in virus translational readthrough. A study in vitro of the determinants of TMV and Mo-MuLV amber suppression.

Authors:  R P Valle; G Drugeon; M D Devignes-Morch; A B Legocki; A L Haenni
Journal:  FEBS Lett       Date:  1992-07-20       Impact factor: 4.124

7.  Suppression of a nonsense mutation in mammalian cells in vivo by the aminoglycoside antibiotics G-418 and paromomycin.

Authors:  J F Burke; A E Mogg
Journal:  Nucleic Acids Res       Date:  1985-09-11       Impact factor: 16.971

8.  Serum IgG antibodies to a 35-kDa P0-related glycoprotein in motor neuron disease.

Authors:  E Nobile-Orazio; E Manfredini; M Sgarzi; G Spagnol; S Allaria; M Quadroni; G Scarlato
Journal:  J Neuroimmunol       Date:  1994-09       Impact factor: 3.478

9.  The cytoplasmic domain of the myelin P0 protein influences the adhesive interactions of its extracellular domain.

Authors:  M H Wong; M T Filbin
Journal:  J Cell Biol       Date:  1994-08       Impact factor: 10.539

10.  Mutations in the cytoplasmic domain of P0 reveal a role for PKC-mediated phosphorylation in adhesion and myelination.

Authors:  W Xu; M Shy; J Kamholz; L Elferink; G Xu; J Lilien; J Balsamo
Journal:  J Cell Biol       Date:  2001-10-22       Impact factor: 10.539

View more
  33 in total

Review 1.  Hydroxylation and translational adaptation to stress: some answers lie beyond the STOP codon.

Authors:  M J Katz; L Gándara; A L De Lella Ezcurra; P Wappner
Journal:  Cell Mol Life Sci       Date:  2016-02-13       Impact factor: 9.261

2.  Phylogenetically Conserved Sequences Around Myelin P0 Stop Codon are Essential for Translational Readthrough to Produce L-MPZ.

Authors:  Yoshihide Yamaguchi; Hiroko Baba
Journal:  Neurochem Res       Date:  2017-10-28       Impact factor: 3.996

3.  Widespread and dynamic translational control of red blood cell development.

Authors:  Juan R Alvarez-Dominguez; Xu Zhang; Wenqian Hu
Journal:  Blood       Date:  2016-11-29       Impact factor: 22.113

4.  Ribosomal readthrough at a short UGA stop codon context triggers dual localization of metabolic enzymes in Fungi and animals.

Authors:  Alina C Stiebler; Johannes Freitag; Kay O Schink; Thorsten Stehlik; Britta A M Tillmann; Julia Ast; Michael Bölker
Journal:  PLoS Genet       Date:  2014-10-23       Impact factor: 5.917

Review 5.  Antiangiogenic VEGF-Ax: A New Participant in Tumor Angiogenesis.

Authors:  Sandeepa M Eswarappa; Paul L Fox
Journal:  Cancer Res       Date:  2015-06-29       Impact factor: 12.701

6.  Translational read-through promotes aggregation and shapes stop codon identity.

Authors:  Lior Kramarski; Eyal Arbely
Journal:  Nucleic Acids Res       Date:  2020-04-17       Impact factor: 16.971

Review 7.  Emerging EPO and EPO receptor regulators and signal transducers.

Authors:  David Kuhrt; Don M Wojchowski
Journal:  Blood       Date:  2015-04-17       Impact factor: 22.113

Review 8.  Nonsense suppression therapies in human genetic diseases.

Authors:  Patrícia Martins-Dias; Luísa Romão
Journal:  Cell Mol Life Sci       Date:  2021-03-22       Impact factor: 9.261

9.  Programmed translational readthrough generates antiangiogenic VEGF-Ax.

Authors:  Sandeepa M Eswarappa; Alka A Potdar; William J Koch; Yi Fan; Kommireddy Vasu; Daniel Lindner; Belinda Willard; Linda M Graham; Paul E DiCorleto; Paul L Fox
Journal:  Cell       Date:  2014-06-19       Impact factor: 41.582

10.  Ribosome profiling reveals pervasive and regulated stop codon readthrough in Drosophila melanogaster.

Authors:  Joshua G Dunn; Catherine K Foo; Nicolette G Belletier; Elizabeth R Gavis; Jonathan S Weissman
Journal:  Elife       Date:  2013-12-03       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.